Demandes d'autorisation

The application for authorisation process includes a period of consultation. It lasts for eight weeks.

Provide your comments

In order to facilitate the work of ECHA's Committees in reviewing the comments received, you are kindly invited to provide your comments in English preferably. By clicking on a link in the table below, you will get access to the full broad information on the use applied for, and to the related commenting form. Comments are welcomed from the EU or beyond.

Consultations close at 23:59 Helsinki time (EET).

Adopted opinions and previous consultations on applications for authorisation

ID	Application type	Name	EC Number	CAS Number	Deadline for consultation	Applicant(s)	Use name
0236-01	Initial	Sodium dichromate	234-190-3	7789-12-0 10588-01-9	13/10/2021	Robur S.p.A	Use of sodium dichromate as an anticorrosion agent of the carbon steel in sealed circuit of gas absorption appliances up to 1.05% w/w (corresponding to 0.42% w/w as Cr VI) in the refrigerant solution
0237-01	Initial	Chromium trioxide	215-607-8	1333-82-0	13/10/2021	Carlo Nobili SPA Rubinetterie	Use at industrial site electroplating of different types of substrates to achieve functional surfaces with high durability and a bright or matt silvery appearance for sanitary applications
0238-01	initial	Chromium trioxide	215-607-8	1333-82-0	13/10/2021	Hueck-Engraving GmbH & Co.KG	Functional chrome plating of high-quality stainless-steel press plates for the premium wood-based materials industry
0239-01	initial	4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated	-	-	13/10/2021	Prionics Lelystad B.V	Use as component of buffer solutions to produce antigens (Cell extraction, cell lysis, coating of biological antigens onto articles, inactivation of microorganisms that produce targeted antigen and solvent exchange) and in-process and final Quality Control of antigens intended for use as veterinary and human health laboratory reagents in Scientific Research and Development and In Vitro Diagnostic applications
0239-02	Initial	4-Nonylphenol, branched and linear, ethoxylated	-	-	13/10/2021	Prionics Lelystad B.V.	Use as component of buffer solutions to produce antigens (Cell extraction, cell lysis, coating of biological antigens onto articles, inactivation of microorganisms that produce targeted antigen and solvent exchange) and in-process and final Quality Control of antigens intended for use as veterinary and human health laboratory reagents in Scientific Research and Development and In Vitro Diagnostic applications
0240-01	Initial	4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated	-	-	13/10/2021	Alexion Pharma International Operations Unlimited Company	Industrial use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated for virus inactivation in the manufacture Andexanet alfa for treatment of adult patients treated with a direct factor Xa (FXa) inhibitor when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding
0241-01	Initial	Chromium trioxide	215-607-8	1333-82-0	13/10/2021	Gessi S.p.A. San Marco Rubinetteria S.r.l.	Use of chromium trioxide for electroplating of metal substrates with the purpose of creating a long-lasting high durability surface with bright look for kitchen and bathroom sanitaryware (functional plating with decorative character)

Export in:

EU Privacy Disclaimer